Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-Peptide Levels: Study Finds

Automated Insulin Delivery Benefits Adults with Type 2 Diabetes

A new study published in Diabetes Care found that automated insulin delivery (AID) systems lower A1C levels and increase time in the glucose range for adults with type 2 diabetes, regardless of their C-peptide levels.

Having a low C-peptide level should not be a prerequisite for AID therapy.

Researchers concluded that AID systems are beneficial for adults with type 2 diabetes, irrespective of C-peptide levels.

Author's summary: AID systems benefit type 2 diabetes patients.

more

Medical Dialogues Medical Dialogues — 2025-10-27

More News